| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.04. | Airsculpt Technologies, Inc. - 10-K/A, Annual Report | - | SEC Filings | ||
| 03.04. | AirSculpt Technologies Non-GAAP EPS of -$0.02, revenue of $33.4M misses by $5.5M | 1 | Seeking Alpha | ||
| 02.04. | AirSculpt expects 2026 revenue of $151M-$157M while targeting net debt leverage below 2.5x | 1 | Seeking Alpha | ||
| 02.04. | Airsculpt Technologies: EPS übertrifft Schätzungen - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 02.04. | Airsculpt Technologies, Inc.: AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results | 133 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., April 02, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 02.04. | Airsculpt Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | Airsculpt Technologies, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| AIRSCULPT TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 18.03. | What's Going On With AirSculpt Stock On Wednesday? | 2 | Benzinga.com | ||
| 16.03. | AirSculpt delays annual report filing, posts $151.8M revenue | 3 | Investing.com | ||
| 16.03. | Airsculpt Technologies, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 16.03. | Airsculpt Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 16.03. | Airsculpt Technologies, Inc.: AirSculpt Technologies Announces Its Intent to Delay the Filing of its Annual Report and Provides Business Update | 2 | GlobeNewswire (USA) | ||
| 17.11.25 | Mike Doyle wird neuer Non-Executive Chairman bei AirSculpt Technologies | 2 | Investing.com Deutsch | ||
| 17.11.25 | AirSculpt Technologies names Mike Doyle as non-executive chairman | 1 | Investing.com | ||
| 17.11.25 | Airsculpt Technologies, Inc.: AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board | 318 | GlobeNewswire (Europe) | MIAMI BEACH, Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)("AirSculpt" or the "Company"), a national provider of premium body contouring procedures, today announced... ► Artikel lesen | |
| 07.11.25 | AirSculpt outlines $153M 2025 revenue outlook as company targets GLP-1-driven growth and margin improvement | 7 | Seeking Alpha | ||
| 07.11.25 | AirSculpt Technologies Shares Drop 43% After Q3 Revenue Decline, Guidance Cut | - | RTTNews | ||
| 07.11.25 | Airsculpt Technologies, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11.25 | AirSculpt Technologies verfehlt Q3-Prognosen deutlich - Aktie bricht ein | 1 | Investing.com Deutsch | ||
| 07.11.25 | AirSculpt Technologies GAAP EPS of -$0.15 misses by $0.12, revenue of $35M misses by $4.8M | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PROGYNY | 16,300 | -1,39 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| BILLIONTOONE | 81,13 | -1,65 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,510 | -4,07 % | Alignment Healthcare (ALHC) Soars 16% on Medicare Reimbursement Hike | ||
| BRIGHTSPRING HEALTH SERVICES | 45,330 | -1,33 % | BrightSpring Health Services, Inc. to Announce First Quarter 2026 Financial Results on May 1, 2026 | ||
| SIEMENS HEALTHINEERS | 37,220 | -0,32 % | ANALYSE-FLASH: Goldman senkt Ziel für Siemens Healthineers - 'Neutral' | NEW YORK (dpa-AFX Broker) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 52 auf 45 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Vor der Berichtssaison... ► Artikel lesen | |
| FRESENIUS | 44,040 | -1,03 % | EQS-News: Fresenius SE & Co. KGaA: FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Rating
FutureFresenius zahlt sich aus: S&P Global Ratings hebt Ausblick für Fresenius SE von stabil auf positiv an
08.04.2026... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,680 | -0,90 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| HEARTFLOW | 26,980 | -0,37 % | Stifel reiterates Heartflow stock rating on clinical data strength | ||
| TALKSPACE | 5,170 | +0,10 % | Universal Health Services, Inc. to Acquire Talkspace, Inc. | Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to care KING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal... ► Artikel lesen | |
| BETA BIONICS | 8,880 | -7,79 % | Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026 | IRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| GENEDX | 59,65 | -0,67 % | Cathie Wood's ARK sells BWX Technologies stock, buys GeneDx | ||
| PRIVIA HEALTH GROUP | 22,370 | -1,50 % | What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in | ||
| PROCEPT BIOROBOTICS | 23,150 | -0,47 % | PROCEPT BioRobotics to Report First Quarter 2026 Financial Results on April 29, 2026 | ||
| CLEARPOINT NEURO | 8,680 | -3,12 % | ClearPoint Neuro, Inc.: ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 | SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,740 | +0,86 % | AKTIE IM FOKUS: Carl Zeiss Meditec erholt - Goldman Sachs verhalten optimistsich | FRANKFURT (dpa-AFX) - Nach verhalten optimistischen Aussagen von Goldman Sachs zu Carl Zeiss Meditec hat die Aktie am Dienstag einen Erholungsversuch unternommen. Am Vormittag ging es um gut drei Prozent... ► Artikel lesen |